CA2390093A1 - Matrice extracellulaire et molecules d'adherence cellulaire - Google Patents
Matrice extracellulaire et molecules d'adherence cellulaire Download PDFInfo
- Publication number
- CA2390093A1 CA2390093A1 CA002390093A CA2390093A CA2390093A1 CA 2390093 A1 CA2390093 A1 CA 2390093A1 CA 002390093 A CA002390093 A CA 002390093A CA 2390093 A CA2390093 A CA 2390093A CA 2390093 A1 CA2390093 A1 CA 2390093A1
- Authority
- CA
- Canada
- Prior art keywords
- xmad
- polynucleotide
- polypeptide
- sequence
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
L'invention concerne une matrice extracellulaire et des molécules d'adhérence cellulaire (XMAD) et des polynucléotides qui identifient et codent ces molécules. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes, ainsi que des méthodes permettant de diagnostiquer, de traiter ou de prévenir des troubles liés à l'expression de ces molécules d'adhérence cellulaire.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17285299P | 1999-12-10 | 1999-12-10 | |
US60/172,852 | 1999-12-10 | ||
US17235499P | 1999-12-16 | 1999-12-16 | |
US60/172,354 | 1999-12-16 | ||
PCT/US2000/032990 WO2001042285A2 (fr) | 1999-12-10 | 2000-12-05 | Matrice extracellulaire et molecules d'adherence cellulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2390093A1 true CA2390093A1 (fr) | 2001-06-14 |
Family
ID=26867999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002390093A Abandoned CA2390093A1 (fr) | 1999-12-10 | 2000-12-05 | Matrice extracellulaire et molecules d'adherence cellulaire |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1244695A2 (fr) |
JP (1) | JP2005503751A (fr) |
AU (1) | AU2575601A (fr) |
CA (1) | CA2390093A1 (fr) |
WO (1) | WO2001042285A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6623923B1 (en) | 1998-12-23 | 2003-09-23 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
AU2375800A (en) | 1998-12-23 | 2000-07-31 | Immunex Corporation | Lectin s3939 dna and polypeptides |
EP1144632A3 (fr) * | 1998-12-23 | 2001-11-07 | Corixa Corporation | Composes destines a l'immunotherapie et au diagnostic du cancer du colon et methodes d'utilisation |
AU2608201A (en) * | 1999-12-30 | 2001-07-16 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
AUPR470101A0 (en) | 2001-05-02 | 2001-05-24 | Murdoch Childrens Research Institute, The | A molecular marker |
US7557196B2 (en) * | 2001-12-07 | 2009-07-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | hGC-1, a gene encoding a member of the olfactomedin-related protein family |
CA2481039A1 (fr) * | 2002-04-01 | 2003-10-16 | Curagen Corporation | Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation |
RU2730661C2 (ru) * | 2018-12-27 | 2020-08-24 | Селл энд Джин Терапи Лтд | Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов COL1A1, COL1A2, P4HA1, P4HA2, COL7A1, CLCA2, ELN, PLOD1 для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-COL1A1, или Escherichia coli SCS110-AF/VTvaf17-COL1A2, или Escherichia coli SCS110-AF/VTvaf17-P4HA1, или Escherichia coli SCS110-AF/VTvaf17-P4HA2, или Escherichia coli SCS110-AF/VTvaf17-COL7A1, или Escherichia coli SCS110-AF/VTvaf17-CLCA2, или Escherichia coli SCS110-AF/VTvaf17-ELN, или Escherichia coli SCS110-AF/VTvaf17- PLOD1, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2328895A1 (fr) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Proteines membranaires et acides nucleiques codant ces proteines |
CA2383244A1 (fr) * | 1999-05-28 | 2000-12-07 | Sugen, Inc. | Proteines kinases |
-
2000
- 2000-12-05 JP JP2001543582A patent/JP2005503751A/ja active Pending
- 2000-12-05 CA CA002390093A patent/CA2390093A1/fr not_active Abandoned
- 2000-12-05 AU AU25756/01A patent/AU2575601A/en not_active Abandoned
- 2000-12-05 EP EP00989218A patent/EP1244695A2/fr not_active Withdrawn
- 2000-12-05 WO PCT/US2000/032990 patent/WO2001042285A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001042285A3 (fr) | 2002-03-07 |
WO2001042285A2 (fr) | 2001-06-14 |
AU2575601A (en) | 2001-06-18 |
EP1244695A2 (fr) | 2002-10-02 |
JP2005503751A (ja) | 2005-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2382015A1 (fr) | Proteines associees a la membrane | |
CA2431493A1 (fr) | Aminoacyl arnt synthetases | |
CA2374745A1 (fr) | Proteases et inhibiteurs de proteases | |
EP1200587A2 (fr) | Recepteurs et proteines associees | |
CA2375493A1 (fr) | Proteines de transport humaines | |
CA2405781A1 (fr) | Proteines secretees | |
CA2410084A1 (fr) | Transporteurs et canaux ioniques | |
CA2379784A1 (fr) | Proteines du cycle et de proliferation cellulaires | |
CA2452501A1 (fr) | Proteines secretees | |
CA2390093A1 (fr) | Matrice extracellulaire et molecules d'adherence cellulaire | |
CA2387785A1 (fr) | Molecules humaines de la transferase | |
EP1179065A2 (fr) | Molecules completes exprimees dans des tissus humains | |
EP1190050A2 (fr) | Proteines de regulateur de transcription humaines | |
CA2384650A1 (fr) | Proteines apoptotiques | |
EP1244700A2 (fr) | Proteines circulant par l'intermediaire de vesicules | |
CA2410679A1 (fr) | Molecules de circulation et de secretion | |
CA2397334A1 (fr) | Proteines secretees | |
US20030044913A1 (en) | Extracellular matrix and cell adhesion molecules | |
CA2336262A1 (fr) | Tri de nexines | |
CA2402747A1 (fr) | Molecules associees a la proteine g | |
WO2001068696A1 (fr) | Proteines de reponse immunitaire humaines | |
CA2375407A1 (fr) | Proteines du metabolisme de l'arn | |
WO2000073450A2 (fr) | Proteines associees au cytosquelette | |
CA2378116A1 (fr) | Molecules de reponse immunologique humaines | |
CA2417676A1 (fr) | Sequences pour l'integrine alpha-8 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |